In NAFLD, the phosphorylation of AMPK is inhibited [23,24], which can directly inhibit the expression levels of HMGCR and SREBP2 in high-fat-diet-induced obesity [25,26]. Here, HMGCR is linked to metabolic dysfunction-associated steatotic liver disease.